Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 79,600 shares, an increase of 907.6% from the April 30th total of 7,900 shares. Based on an average daily trading volume, of 90,300 shares, the days-to-cover […]
Maxim Group reissued their hold rating on shares of Virpax Pharmaceuticals (NASDAQ:VRPX – Free Report) in a research note released on Wednesday morning, Marketbeat.com reports. Virpax Pharmaceuticals Stock Performance VRPX stock opened at $0.72 on Wednesday. Virpax Pharmaceuticals has a 1-year low of $0.63 and a 1-year high of $11.77. The business’s 50 day moving […]
Shares of Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Free Report) are going to reverse split before the market opens on Friday, March 1st. The 1-10 reverse split was announced on Friday, March 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, March 1st. Virpax Pharmaceuticals Price Performance Shares […]
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 51,500 shares, a decrease of 44.1% from the December 31st total of 92,100 shares. Currently, 0.6% of the company’s stock are sold short. Based on an […]
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totalling 92,100 shares, an increase of 479.2% from the December 15th total of 15,900 shares. Based on an average trading volume of 270,600 shares, the days-to-cover ratio […]